# OnCo record visugromab (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/visugromab/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "visugromab" ;
  schema:name "Visugromab"@en ;
  schema:description "Visugromab is CatalYm's antibody against GDF-15, a tumour-made signal that both blocks immune cells and causes cancer wasting; it is in a phase 3 trial with PD-1 blockade after durable responses in patients whose cancers had stopped responding to checkpoint inhibitors."@en ;
  schema:url <https://onco.cc/drugs/visugromab/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=CTL-002> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Anti-GDF-15 monoclonal antibody, intravenous" ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:companies <https://onco.cc/companies/catalym/> ;
  onco:trials <https://onco.cc/trials/nct07112196/>, <https://onco.cc/trials/nct07219459/>, <https://onco.cc/trials/nct07098988/>, <https://onco.cc/trials/nct07246863/>, <https://onco.cc/trials/nct04725474/> .